EMA: Possible Link between J,J Vaccine, Rare Blood Clots Found

The major European drug regulator, European Medicines Agency (EMA), has found a possible link between Johnson and Johnson (J&J) COVID-19 vaccine, and rare blood clotting, EMA said on Tuesday.

It added that blood clotting should be mentioned as a possible or a rare side effect of the vaccine, therefore, a warning should be added on J&J vaccine doses labels.

Therefore, the agency asserted that the advantages of the vaccine are higher than the rare possibility of blood clotting.

Last week, a US citizen died and another one was in critical condition after receiving J&J vaccine after suffering from blood clotting complications, according to Food and Drug Administration (FDA).

Until now Six women whose ages wanderer between 18 to 48 years old suffered from rare brain blood clots after receiving the J&J jab.

“One case was fatal, and one patient is in critical condition,” FDA senior member Peter Marks told media agencies.

Therefore, federal advice has recommended suspending using the vaccine after receiving several negative reports from recipients.

Senior Centers for Disease Control and Prevention official Anne Schuchat said: “For people who recently got the vaccine within the last couple of weeks, they should be aware to look for any symptoms.

She continued, “If you’ve received a vaccine and develop severe headaches, abdominal pain, leg pain, or shortness of breath, you should contact your health care provider.”